VAP-cyclo protocol

chemotherapy protocol consisting of above cpds; used in treatment of advanced breast cancer and non-Hodgkin's lymphoma; do not confuse with CHOP protocol which contains prednisone instead of prednisolone

Also Known As:

Networked: 171 relevant articles (35 outcomes, 26 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1.	Guan, Zhong-Zhen: 5 articles (12/2007 - 04/2003)
2.	Zhu, Jun: 4 articles (03/2015 - 12/2005)
3.	Tsurumi, Hisashi: 4 articles (01/2014 - 11/2002)
4.	Moriwaki, Hisataka: 4 articles (01/2014 - 11/2002)
5.	Jiang, Wen-Qi: 4 articles (02/2009 - 08/2003)
6.	He, You-Jian: 4 articles (12/2007 - 04/2003)
7.	Xia, Yi: 3 articles (10/2015 - 12/2007)
8.	Hong, Xiaonan: 3 articles (03/2015 - 06/2012)
9.	Takami, Tsuyoshi: 3 articles (01/2014 - 05/2012)
10.	Goto, Naoe: 3 articles (01/2014 - 05/2012)

Related Diseases

1.	Non-Hodgkin Lymphoma (Lymphosarcoma) 10/01/2012 - "The patient was put on CHOP regimen targeted for high grade lymphomas, and had complete remission. " 08/01/2003 - "For newly diagnosed non-Hodgkin's lymphoma (NHL), CHOP regimen shows good response, but quite a few patients belong to intrinsic drug resistance, or relapse after complete remission (CR). " 10/01/1995 - "Until now, literature data support the fact that the CHOP regimen represents the standard first line treatment for patients with advanced intermediate-grade non-Hodgkin's lymphoma. " 03/01/2000 - "Since the study by SWOG in 1993, CHOP regimen has been the standard therapy for patients with advanced stage intermediate-grade or high-grade non-Hodgkin's lymphoma. " 04/01/2011 - "Thirty patients with newly diagnosed non-Hodgkin lymphoma (NHL) treated with the first course of an R-CHOP regimen were enrolled randomly. "
2.	Lymphoma (Lymphomas) 10/15/2013 - "The study indicated that cardiovascular mortality in lymphoma patients treated with (R)-CHOP regimen is relatively high and ECG monitoring may be the most effective in cardiological risk assessment. " 02/01/2009 - "The patient was treated with 6 courses of CHOP regimen, resulting in complete remission of lymphoma. " 08/01/2011 - "In conclusion, we can point out that intensification could enhance the efficacy of the R-CHOP regimen and improve overall survival in patients with non germinal lymphoma." 10/01/1998 - "The M-CHOP regimen seems to be a promising treatment for primary malignant lymphoma in the central nervous system." 12/01/1996 - "The efficacy of dose intensification of CPA in CHOP regimen for patients with aggressive lymphoma is being investigated in some clinical trials. "
3.	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell) 06/01/2010 - "The R-CHOP regimen has been found to improve the outcome of diffuse large B-cell lymphoma (DLBCL). " 08/01/1984 - "Long-term remission durability and functional status of patients treated for diffuse histiocytic lymphoma with the CHOP regimen." 10/01/2015 - "Our results indicate that survivin is an independent prognostic factor for poor outcome in patients with activated B cell-like disease treated with the R-CHOP regimen, and patients with survivin-positive activated B cell-like diffuse large B-cell lymphoma seem to benefit less from this treatment and may require additional novel agents. " 01/01/2015 - "Here we describe a case of PSL detected by ¹⁸F-FDG-PET/CT which was histopathologically proven to be diffuse large B-cell lymphoma (DLBCL) treated with CHOP regimen. " 12/01/2014 - "ALDH1A1 mediates resistance of diffuse large B cell lymphoma to the CHOP regimen."
4.	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 02/01/2013 - "Efficacy of a dose-intensified CHOP (Double-CHOP) regimen for peripheral T-cell lymphomas." 11/01/2004 - "[Clinical outcomes of 106 patients with peripheral T-cell lymphoma treated by standard CHOP regimen]." 11/01/2004 - "This study was designed to analyse the clinical characteristics and to evaluate the effectiveness and toxicity of standard CHOP regimen in the treatment of peripheral T-cell lymphomas-unspecified (PTCL-U) according to the Revised European- American Lymphoma (REAL) classification. " 01/01/2006 - "We investigated the efficacy of a dose-intensified double-CHOP regimen followed by high-dose chemotherapy with or without peripheral blood stem cell transplantation (PBSCT) in 11 patients with four types of peripheral T-cell lymphoma (PTCL). " 01/01/2006 - "Treatment of high-risk peripheral T-cell lymphomas other than anaplastic large-cell lymphoma with a dose-intensified CHOP regimen followed by high-dose chemotherapy. "
5.	Neoplasms (Cancer) 05/01/1991 - "She was treated with CHOP regimen and irradiation, resulting of decreased tumor size and population of CD4+/CD8+." 11/01/2004 - "106 patients with PTCL-U were treated by standard CHOP regimen with or without involved field radiotherapy from January 1997 to December 2003 in Cancer Center, Sun Yat-sen University, The clinical characteristics, response and long-term survival rates were analysed, retrospectively. " 02/01/1998 - "The tumor cells were detected in her peripheral blood despite four courses of combination chemotherapy using CHOP regimen. " 09/01/1996 - "The patient received three cycles (every 21 days) of CHOP regimen for Non Hodgkin's lymphoma and to maintain a static state of oesophageal cancer. " 01/01/2009 - "Immunosuppression reduction, chemotherapy with CHOP regimen and local radiotherapy induced complete remission of the tumor."

Related Drugs and Biologics

1.	Doxorubicin (Adriamycin)
2.	Vincristine (Oncovin)
3.	Cyclophosphamide (Cytoxan)
4.	rituximab (Mabthera)
5.	Prednisone (Sone)
6.	Prednisolone (Predate)
7.	Etoposide (VP 16)
8.	Granulocyte Colony-Stimulating Factor (G-CSF)
9.	Idarubicin (4 Demethoxydaunorubicin)
10.	Cisplatin (Platino)

Related Therapies and Procedures

1.	Drug Therapy (Chemotherapy)
2.	Radiotherapy
3.	Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation)
4.	Aftercare (After-Treatment)
5.	Stem Cell Transplantation